Lowest Price Guaranteed From USD 4,899
Published
July 2020
Pages
132
View Count
1093
Example Insights
Report Description
The ‘Multi-drug Resistant Tuberculosis Market, 2020-2030’ report features comprehensive insights about the current market landscape consisting of several industry stakeholders engaged in developing disease modifying interventions, drug products and therapies that have been developed / are being developed for the treatment of condition as well as the market trends across various geographical regions (North America, Europe and Asia-Pacific).
This report provides an informed opinion on the likely adoption of therapeutics designed to treat multi-drug resistant tuberculosis. It features an in-depth analysis, highlighting the current treatment practices, emerging drugs, and market share of the individual therapies. In addition to other elements, the study includes detailed assessment of the current market landscape, providing information about the product’s mechanism of action, dosage and administration, and pharmacological studies, regulatory milestones, and other development activities.
One of the key objectives of the report was to estimate the existing market size and the future opportunity of therapies for multi-drug resistant tuberculosis, over the next decade. Based on multiple parameters, such as disease prevalence, anticipated adoption of the forecasted therapies and the likely selling price of such therapeutic products, we have provided informed estimates on the evolution of the market for the period 2020-2030.
Contents
1. PREFACE
2. EXECUTIVE SUMMARY
3. INTRODUCTION
4. CURRENT MARKET LANDSCAPE
4.1. Multi-Drug Resistant Tuberculosis Therapies: Marketed and Development Pipeline
4.1.1. Analysis by Type of Molecule
4.1.2. Analysis by Phase of Development
4.1.3. Analysis by Mechanism of Action
4.1.4. Analysis by Route of Administration
4.1.5. Analysis by Dosage Form
4.1.6. Analysis by Target Patient Population
4.2. Multi-Drug Resistant Tuberculosis Therapies: Developer Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size and Location of Headquarters
4.2.3. Analysis by Geography
5. COMPANY PROFILES
6. PUBLICATION ANALYSIS
7. PARTNERSHIPS AND COLLABORATIONS
8. FUNDING AND INVESTMENT ANALYSIS
9. MARKET SIZING AND OPPORTUNITY ANALYSIS
9.1. Multi-Drug Resistant Tuberculosis Market: Distribution by Type of Molecule
9.2. Multi-Drug Resistant Tuberculosis Market: Distribution by Route of Administration
9.3. Multi-Drug Resistant Tuberculosis Market: Distribution by Dosage Form
9.4. Multi-Drug Resistant Tuberculosis Market: Distribution by Region
10. EXECUTIVE INSIGHTS
11. CONCLUDING REMARKS
12. APPENDIX 1: TABULATED DATA
13. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS